Department of Clinical and Diagnostic Sciences, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
J Genet Couns. 2023 Oct;32(5):1088-1101. doi: 10.1002/jgc4.1719. Epub 2023 May 15.
Neurofibromatosis 1 (NF1) is a common genetic disorder typically diagnosed in childhood and characterized by cutaneous findings, nerve sheath tumors, skeletal abnormalities, malignancies, and developmental differences. Due to its variability, NF1 is an unpredictable condition that parents have concerns about discussing with their children. While there are publications addressing the disclosure of genetic conditions in general, no NF1-specific disclosure literature exists. To fill this gap, this mixed methods study sought to evaluate the concerns, barriers, failures, or successes parents or guardians have experienced when they have or have not chosen to tell their child(ren) about an NF1 diagnosis. Parents of children between ages 0 and 17 with a diagnosis of NF1 completed a survey and some parents were selected for an interview invitation. A total of 258 surveys were completed, and 20 parents were interviewed. Interview transcripts were categorized into disclosure and non-disclosure groups. Themes were organized into five categories based on interview questions: disclosure concerns, factors affecting disclosure/non-disclosure, approaches to disclosure, desired resources, and recommendations for disclosure. Sentiment analysis was performed on responses about the disclosure discussion itself. Results indicated that most parents (70.5%) disclosed the NF1 diagnosis to their child and overall felt it was a positive experience. Almost one-third of parents (29.5%) had not disclosed the diagnosis. A strong significance was identified between disclosure and severe presentation of NF1 (p = 0.0008). Parents in both groups shared similar concerns about discussing the diagnosis and multiple factors influenced the disclosure decision. Most parents approached disclosure as a process and emphasized the need to be honest and supportive of their child. Parents highlighted the need for more educational resources for children and guidance on how to disclose. These findings indicate that additional resources and support for parents would facilitate disclosure and the involvement of genetic counselors in the process would be beneficial.
神经纤维瘤病 1 型(NF1)是一种常见的遗传性疾病,通常在儿童时期被诊断出来,其特征为皮肤表现、神经鞘瘤、骨骼异常、恶性肿瘤和发育差异。由于其变异性,NF1 是一种不可预测的疾病,父母对此会有所担忧,并考虑是否要与孩子讨论。虽然有一些出版物涉及一般遗传状况的披露,但没有针对 NF1 特定披露的文献。为了填补这一空白,这项混合方法研究旨在评估父母在选择是否告知孩子 NF1 诊断时所经历的担忧、障碍、失败或成功。患有 NF1 的 0 至 17 岁儿童的父母完成了一项调查,一些父母被选为接受访谈邀请。共完成了 258 份调查问卷,20 位父母接受了访谈。访谈记录被分类为披露组和非披露组。根据访谈问题,主题被组织成五个类别:披露关注、影响披露/非披露的因素、披露方法、所需资源和披露建议。对关于披露讨论本身的回答进行了情感分析。结果表明,大多数父母(70.5%)向孩子透露了 NF1 诊断,总体而言,他们认为这是一次积极的经历。近三分之一的父母(29.5%)没有透露诊断结果。披露和 NF1 严重表现之间存在显著差异(p=0.0008)。两组父母在讨论诊断时都有类似的担忧,并且有多个因素影响了披露决定。大多数父母将披露视为一个过程,并强调诚实和支持孩子的重要性。父母强调需要为孩子提供更多的教育资源,以及关于如何披露的指导。这些发现表明,为父母提供更多的资源和支持将有助于披露,并且遗传咨询师参与该过程将是有益的。